Pancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy

Objective. Roux-en-Y gastric bypass (RYGB) is an independent risk factor for moderate hypocalcaemia and may lead to the development of resistant hypocalcaemia following thyroid surgery.

Guardado en:
Detalles Bibliográficos
Autores principales: Baldane S, Ipekci SH, Kebapcilar L
Formato: article
Lenguaje:EN
Publicado: Sciendo 2016
Materias:
Acceso en línea:https://doaj.org/article/382e6b669d334c38a16106e7234862a1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:382e6b669d334c38a16106e7234862a1
record_format dspace
spelling oai:doaj.org-article:382e6b669d334c38a16106e7234862a12021-12-02T15:29:49ZPancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy1336-032910.1515/enr-2016-0006https://doaj.org/article/382e6b669d334c38a16106e7234862a12016-01-01T00:00:00Zhttps://doi.org/10.1515/enr-2016-0006https://doaj.org/toc/1336-0329Objective. Roux-en-Y gastric bypass (RYGB) is an independent risk factor for moderate hypocalcaemia and may lead to the development of resistant hypocalcaemia following thyroid surgery.Baldane SIpekci SHKebapcilar LSciendoarticlebariatric surgeryhypocalcaemiahypoparathyroidismthyroidectomyDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENEndocrine Regulations, Vol 50, Iss 1, Pp 27-31 (2016)
institution DOAJ
collection DOAJ
language EN
topic bariatric surgery
hypocalcaemia
hypoparathyroidism
thyroidectomy
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle bariatric surgery
hypocalcaemia
hypoparathyroidism
thyroidectomy
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Baldane S
Ipekci SH
Kebapcilar L
Pancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy
description Objective. Roux-en-Y gastric bypass (RYGB) is an independent risk factor for moderate hypocalcaemia and may lead to the development of resistant hypocalcaemia following thyroid surgery.
format article
author Baldane S
Ipekci SH
Kebapcilar L
author_facet Baldane S
Ipekci SH
Kebapcilar L
author_sort Baldane S
title Pancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy
title_short Pancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy
title_full Pancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy
title_fullStr Pancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy
title_full_unstemmed Pancrelipase treatment in a patient with the history of Roux-en-Y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy
title_sort pancrelipase treatment in a patient with the history of roux-en-y gastric bypass operation that developed resistant hypocalcemia secondary to total thyroidectomy
publisher Sciendo
publishDate 2016
url https://doaj.org/article/382e6b669d334c38a16106e7234862a1
work_keys_str_mv AT baldanes pancrelipasetreatmentinapatientwiththehistoryofrouxenygastricbypassoperationthatdevelopedresistanthypocalcemiasecondarytototalthyroidectomy
AT ipekcish pancrelipasetreatmentinapatientwiththehistoryofrouxenygastricbypassoperationthatdevelopedresistanthypocalcemiasecondarytototalthyroidectomy
AT kebapcilarl pancrelipasetreatmentinapatientwiththehistoryofrouxenygastricbypassoperationthatdevelopedresistanthypocalcemiasecondarytototalthyroidectomy
_version_ 1718387136534675456